VanderLaan PA - Search Results

1

Macrophage migration inhibitory factor as a novel biomarker of portopulmonary hypertension.

DuBrock HM, Rodriguez-Lopez JM, LeVarge BL, Curry MP, VanderLaan PA, Zsengeller ZK, Pernicone E, Preston IR, Yu PB, Nikolic I, Xu D, Thadhani RI, Channick RN, Ananth Karumanchi S. DuBrock HM, et al. Among authors: vanderlaan pa. Pulm Circ. 2016 Dec;6(4):498-507. doi: 10.1086/688489. Pulm Circ. 2016. PMID: 28090291 Free PMC article.

2

Vascular remodeling of the small pulmonary arteries and measures of vascular pruning on computed tomography.

Synn AJ, Margerie-Mellon C, Jeong SY, Rahaghi FN, Jhun I, Washko GR, Estépar RSJ, Bankier AA, Mittleman MA, VanderLaan PA, Rice MB. Synn AJ, et al. Among authors: vanderlaan pa. Pulm Circ. 2021 Nov 29;11(4):20458940211061284. doi: 10.1177/20458940211061284. eCollection 2021 Oct-Dec. Pulm Circ. 2021. PMID: 34881020 Free PMC article.

3

A 50-year-old man with cirrhosis and progressive hypoxemia.

Burke KE, VanderLaan PA, Folch E, Curry MP, McSparron JI. Burke KE, et al. Among authors: vanderlaan pa. Ann Am Thorac Soc. 2014 Sep;11(7):1149-51. doi: 10.1513/AnnalsATS.201405-211CC. Ann Am Thorac Soc. 2014. PMID: 25237994 No abstract available.

4

Comparative genomic and immunopathologic analysis of lung adenocarcinomas with and without cytology-proven malignant pleural effusions.

Pineda CM, Majid A, Costa DB, VanderLaan PA. Pineda CM, et al. Among authors: vanderlaan pa. Cancer Cytopathol. 2024 Dec;132(12):788-798. doi: 10.1002/cncy.22900. Epub 2024 Aug 29. Cancer Cytopathol. 2024. PMID: 39207725

5

Osseous and chondromatous metaplasia in calcific aortic valve stenosis.

Torre M, Hwang DH, Padera RF, Mitchell RN, VanderLaan PA. Torre M, et al. Among authors: vanderlaan pa. Cardiovasc Pathol. 2016 Jan-Feb;25(1):18-24. doi: 10.1016/j.carpath.2015.08.008. Epub 2015 Aug 29. Cardiovasc Pathol. 2016. PMID: 26386747 Free article.

6

Tumor biomarker testing in non-small-cell lung cancer: A decade of change.

VanderLaan PA, Rangachari D, Majid A, Parikh MS, Gangadharan SP, Kent MS, McDonald DC, Huberman MS, Kobayashi SS, Costa DB. VanderLaan PA, et al. Lung Cancer. 2018 Feb;116:90-95. doi: 10.1016/j.lungcan.2018.01.002. Epub 2018 Jan 4. Lung Cancer. 2018. PMID: 29413057 Free PMC article.

7

Non-small cell lung cancer predictive biomarker testing via immunocytochemistry: Ways of future past?

VanderLaan PA. VanderLaan PA. Cancer Cytopathol. 2019 May;127(5):278-280. doi: 10.1002/cncy.22138. Epub 2019 May 3. Cancer Cytopathol. 2019. PMID: 31050221 Free article. No abstract available.

8

Correlation between Classic Driver Oncogene Mutations in EGFR, ALK, or ROS1 and 22C3-PD-L1 ≥50% Expression in Lung Adenocarcinoma.

Rangachari D, VanderLaan PA, Shea M, Le X, Huberman MS, Kobayashi SS, Costa DB. Rangachari D, et al. Among authors: vanderlaan pa. J Thorac Oncol. 2017 May;12(5):878-883. doi: 10.1016/j.jtho.2016.12.026. Epub 2017 Jan 16. J Thorac Oncol. 2017. PMID: 28104537 Free PMC article.

9

Growth Assessment of Pulmonary Adenocarcinomas Manifesting as Subsolid Nodules on CT: Comparison of Diameter-Based and Volume Measurements.

de Margerie-Mellon C, Gill RR, Monteiro Filho AC, Heidinger BH, Onken A, VanderLaan PA, Bankier AA. de Margerie-Mellon C, et al. Among authors: vanderlaan pa. Acad Radiol. 2020 Oct;27(10):1385-1393. doi: 10.1016/j.acra.2019.09.028. Epub 2019 Nov 13. Acad Radiol. 2020. PMID: 31732419

10

Current and future trends in non-small cell lung cancer biomarker testing: The American experience.

VanderLaan PA, Roy-Chowdhuri S. VanderLaan PA, et al. Cancer Cytopathol. 2020 Sep;128(9):629-636. doi: 10.1002/cncy.22313. Cancer Cytopathol. 2020. PMID: 32885913 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

157 results

Search Page

Filters